VictoriaLouiseSeewaldtMD

Oncology • Duarte, CA

Breast Cancer

Professor

Join to view full profile

Dr. Seewaldt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Seewaldt's full profile

Already have an account?

Office
1500 Duarte Rd
Duarte, CA 91010
Phone+1 626-256-4673

Fax+1 626-218-5310

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1992 - 1995
University of WashingtonResidency, Internal Medicine, 1990 - 1992
University of California, Davis, School of MedicineClass of 1989

Certifications & Licensure

CA State Medical License 2015 - 2025
NC State Medical License 2000 - 2016
OH State Medical License 1998 - 2000
WA State Medical License 1989 - 1999

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Statins and Breast Cancer Biomarkers Start of enrollment: 2005 Jan 01
Unknown status
Phase 2
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients Start of enrollment: 2017 Oct 13
Active, not recruiting
Not Applicable

Publications & Presentations

PubMed

Multiparametric profiling of HER2-enriched extracellular vesicles in breast cancer using Single Extracellular VEsicle Nanoscopy.
Nan Jiang, Andras Saftics, Eugenia Romano, Ima Ghaeli, Cristal Resto
Journal of Nanobiotechnology. 2024-09-28
Insulin Resistance in Women Correlates with Chromatin Histone Lysine Acetylation, Inflammatory Signaling, and Accelerated Aging.
Christina M Vidal, Jackelyn A Alva-Ornelas, Nancy Zhuo Chen, Parijat Senapati, Jerneja Tomsic
Cancers. 2024-08-01
2 citations
Cooperation between PRMT1 and PRMT6 drives lung cancer health disparities among Black/African American men.
Pei-Ying Wu, Michelle Van Scoyk, Stephanie S McHale, Chu-Fang Chou, Gregory Riddick
Iscience. 2024-02-16

Press Mentions

Racial, Economic Segregation Linked to Cancer MortalityNovember 17th, 2022
National Cancer Center Is Pleased to Name David Knorr, M.D., Ph.D., to Scientific Advisory BoardOctober 25th, 2022
National Cancer Center Announces Recipients of 2021-22 Research Fellowship AwardsJune 16th, 2021
Join now to see all

Grant Support

Targeted Chemoprevention Of Breast Cancer: From The Bench To Clinical TestingNational Cancer Institute2012
KCNK9 Imprinting In Breast Cancer Progression And MetastasisNational Cancer Institute2011–2012
Molecular Markers Of Breast Cancer Risk And PreventionNational Cancer Institute2006–2010
Ecm-Mediated Apoptosis In P53 (-) HmecsNational Cancer Institute2006–2010
P53 Loss In Hmecs: A Model Of Breast Cancer PreventionNational Cancer Institute2003–2007
Extracellular Matrix Mediated Apoptosis In P53 (-) HmecsNational Cancer Institute2001–2005
RAR Beta Mediated Apoptosis In Breast Cancer CellsNational Cancer Institute1999
RAR Beta Mediated Apoptosis In Breast Cancer CellsNational Cancer Institute1998–1999
RAR Beta Mediated Apoptosis In Breast Cancer CellsNational Cancer Institute1995–1997